Skip to main content
TipRanks
Go Ultimate75% OFF

Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) AI Stock Analysis

2 Followers
HK:1501

Shanghai Kindly Medical Instruments Co., Ltd. Class H

(HKEX:1501)

Select Model
Rating:73Outperform
Price Target:HKD 32.00▲(8.70% Upside)
Action:upgraded
Date:11/07/26

Strong financial performance is the primary support, led by revenue growth, profitability, and improved cash generation. This is offset by bearish technical positioning and only moderate valuation support, producing an overall score of 73.

Positive Factors
Revenue GrowthSteady revenue expansion, including 12.7% growth in 2025, indicates continued demand for the company’s medical devices and consumables. Sustained sales growth can broaden clinical adoption, support operating scale, and provide a durable base for investment in product development and commercialization.
Negative Factors
Margin CompressionThe multi-year decline in net margin, alongside a gross-margin dip in 2025, signals pressure from rising costs, pricing, or product mix. If sustained, compression would reduce earnings conversion from future sales and limit the benefit of otherwise healthy revenue growth.

Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) vs. iShares MSCI Hong Kong ETF (EWH)

-10%0%10%20%30%40%HK:1501-1.09%EWH+8.92%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
HKD 4.82B
Dividend Yield
0.89%
Average Volume (3M)
194.95K
Price to Earnings (P/E)
21.1
Beta (1Y)
-0.04
Revenue Growth
34.94%
EPS Growth
12.99%
Country
Hong Kong
Employees
2,180
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

Shanghai Kindly Medical Instruments Co., Ltd. Class H Business Overview & Revenue Model

Company Description

Shanghai Kindly Medical Instruments Co., Ltd., founded in 2006 and based in Shanghai, China, focuses on the research, development, production, and international sales of cardiovascular interventional medical devices. The company's products reach cust...

How the Company Makes Money

The company primarily makes money by selling medical devices and related disposable/consumable products to healthcare providers (e.g., hospitals and clinics), generating revenue on a per-unit basis through product shipment/recognized sales. Revenue i...

Shanghai Kindly Medical Instruments Co., Ltd. Class H Financial Statement Overview

Summary

Strong revenue growth, sustained profitability, expanding equity, manageable leverage, and sharply improved free cash flow support a high score; rising debt and prior cash-flow volatility are moderate risks.

Income Statement

88Very Positive

Balance Sheet

82Very Positive

Cash Flow

85Very Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.19B1.07B851.95M752.84M585.88M464.68M
Gross Profit725.48M636.79M537.66M438.07M332.49M275.75M
EBITDA386.17M362.52M292.50M225.88M166.42M174.85M
Net Income229.06M218.79M191.91M156.46M131.71M142.96M
Balance Sheet
Total Assets3.87B3.13B2.26B2.03B1.83B1.62B
Cash, Cash Equivalents and Short-Term Investments1.32B630.81M554.51M434.40M528.27M640.55M
Total Debt716.25M716.26M243.69M94.78M48.83M13.40M
Total Liabilities1.03B1.04B473.39M351.25M273.23M183.63M
Stockholders Equity2.76B2.00B1.77B1.65B1.51B1.40B
Cash Flow
Free Cash Flow377.34M278.17M59.80M-53.05M-62.75M-205.07M
Operating Cash Flow445.91M340.98M225.54M178.15M180.46M72.76M
Investing Cash Flow-389.31M-491.99M-187.31M-283.81M-316.18M-268.08M
Financing Cash Flow791.38M263.40M56.97M8.06M9.72M-31.07M

Shanghai Kindly Medical Instruments Co., Ltd. Class H Technical Analysis

Technical Analysis SentimentNegative
Last Price29.44

Price Trends

50DMA32.06Negative
100DMA32.40Negative
200DMA32.80Negative

Market Momentum

MACD-0.70Negative
RSI42.84Neutral
STOCH60.68Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1501, the sentiment is Negative. The current price of 29.44 is below the 20-day moving average (MA) of 29.89, below the 50-day MA of 32.06, and below the 200-day MA of 32.80, indicating a bearish trend. The MACD of -0.70 indicates Negative momentum. The RSI at 42.84 is Neutral, neither overbought nor oversold. The STOCH value of 60.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1501.

Shanghai Kindly Medical Instruments Co., Ltd. Class H Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

HK:1501 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:3600HK:360080OutperformHKD 6.53B9.5920.11%4.14%12.50%44.44%
HK:6929HK:692978OutperformHKD 3.03B8.7410.50%5.43%16.25%7.80%
HK:1066HK:106673OutperformHKD 14.61B9.155.64%5.21%7.47%-26.89%
HK:1501HK:150173OutperformHKD 6.20B21.159.64%0.89%34.94%12.99%
HK:6699HK:669966NeutralHKD 13.53B40.218.95%12.79%――
HK:1358HK:135861NeutralHKD 1.27B26.451.10%3.48%-1.64%-68.67%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-25%0%25%50%HK:1501HK:1066HK:1358HK:3600HK:6699HK:6929Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HK:1501 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:1501Shanghai Kindly Medical Instruments Co., Ltd. Class H29.44-0.34-1.15%
HK:1066Shandong Weigao Group Medical Polymer Co Class H3.28-1.75-34.80%
HK:1358PW Medtech Group Ltd.0.90-0.42-32.09%
HK:3600Modern Dental Group Limited7.132.2646.41%
HK:6699Angelalign Technology Inc.79.9021.9037.75%
HK:6929OrbusNeich Medical Group Holdings Limited3.91-0.06-1.51%

Shanghai Kindly Medical Instruments Co., Ltd. Class H Corporate Events

Shanghai INT Medical Grants Major H-Share Award to Chairman Under Incentive Scheme

Oct 12, 2026

Shanghai INT Medical Instruments Co., Ltd. has expanded its H Share Award and Trust Scheme with a significant new grant to chairman and general manager Dr. Liang. Under the scheme, an independent trustee purchases existing H shares on the market usin...

Shanghai Kindly Medical Moves to Dual Listing with A Share Issuance

Oct 11, 2026

Shanghai Kindly Medical Instruments Co., Ltd., a medical device manufacturer incorporated in the PRC and listed in Hong Kong, plans to expand its listing footprint to the ChiNext Market of the Shenzhen Stock Exchange. The company’s H shares will be c...

Shanghai INT Medical Instruments Wins Shareholder Backing for Board Shake-Up and Governance Changes

Sep 24, 2026

Shanghai INT Medical Instruments Co., Ltd. held its first extraordinary general meeting of 2026 in Shanghai, where all directors attended either in person or electronically and the meeting procedures were confirmed to comply with PRC Company Law and...

Shanghai INT Medical Clarifies Board Composition and Committee Roles

Sep 24, 2026

Shanghai INT Medical Instruments Co., Ltd. has released an updated list of its board of directors, detailing the composition of executive, non-executive, employee representative, and independent non-executive members. The announcement underscores the...

Shanghai INT Medical Clarifies Sellers in Healthcare Equity Acquisition

Sep 11, 2026

Shanghai INT Medical Instruments Co., Ltd., a Hong Kong-listed Chinese medical device maker, operates in the healthcare sector with a focus on medical instruments and related technologies. Its shareholder base includes healthcare-focused and general...

Shanghai INT Medical Instruments Calls EGM to Revamp Board and Governance Framework

Sep 8, 2026

Shanghai INT Medical Instruments Co., Ltd., a PRC-incorporated medical device manufacturer listed in Hong Kong under stock code 1501, designs and produces medical instruments from its Shanghai headquarters, supported by a principal office in Hong Kon...

Shanghai INT Medical Reshapes Board as It Prepares Mainland A-Share Listing

Aug 24, 2026

Shanghai INT Medical Instruments announced several board changes as it prepares for a mainland A-share listing, including the resignation of non-executive director Wang Ruiqin due to personal work adjustments. The company also disclosed that long-ser...

Shanghai INT Medical Instruments Sets Out Board and Committee Structure

Aug 24, 2026

Shanghai INT Medical Instruments Co., Ltd. has detailed the composition of its board of directors, which includes two executive directors, four non-executive directors, an employee representative director and three independent non-executive directors...

Shanghai INT Medical Instruments Boosts Revenue and Margins on Interventional Device Growth

Aug 24, 2026

Shanghai INT Medical Instruments reported robust growth for the six months ended 30 June 2026, with revenue rising 29.28% to RMB596.06 million, driven mainly by stronger sales of interventional medical devices. Revenue from these core products climbe...

Shanghai Kindly Medical Sets Board Meeting to Approve Interim Results and Consider Dividend

Aug 12, 2026

Shanghai Kindly Medical Instruments Co., Ltd., a PRC-incorporated joint stock company listed in Hong Kong, operates in the medical instruments industry, supplying a range of healthcare-related devices through its subsidiaries. Its board comprises exe...

Shanghai INT Medical Sets Extraordinary General Meeting and Closes Register of Members

Aug 10, 2026

Shanghai INT Medical Instruments Co., Ltd. has scheduled its first extraordinary general meeting of 2026 for 24 September, and will temporarily close its register of members from 25 August to 24 September to determine shareholder eligibility. Share t...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026